DWAS Fact Sheet: Invesco Dorsey Wright SmallCap Momentum ETF
Share
$99.88
close, Nov 18, 2026
Over the year to Nov 18, 2026, DWAS returned +9.7% in total and charged 0.60% a year.
- 1-year total return
- +9.7%
- IWV +12.0% to Nov 18, 2026
- Expense ratio
- 0.60%
- a year
- Net assets
- $367m
- on Nov 17, 2026
- Net flow, last 5 trading days
- −$2.1m
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
DWAS $10,971 +9.7% · IWV $11,199 +12.0% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−2.0%
3 months−13.3%
Year to date+3.3%
1 year+9.7%
3 years+35.9%
5 years+8.8%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Replimune Group Inc1.88%
Amneal Pharmaceuticals Inc1.81%
Oruka Therapeutics Inc1.57%
Alto Neuroscience Inc1.48%
Adaptive Biotechnologies Corp1.43%
Acadian Asset Management Inc1.43%
Victory Capital Holdings Inc1.43%
Xometry Inc1.25%
Frequency Electronics Inc1.24%
Northeast Bank1.04%
DWAS top ten by weight, 14.6% of the fund, of its 202 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the Dorsey Wright SmallCap Tech Leaders Index · First traded Jul 19, 2012 · Benchmark Russell 3000 Index, measured by IWV, which tracks the same index